CATALYST PHARMACEUTICALS INC (CPRX) Institutional Ownership and Insiders Activity
CATALYST PHARMACEUTICALS INC (CPRX) is widely held by institutional investors, with 381 firms reporting positions valued at approximately $3.33B based on SEC Form 13F filings for the quarter ended June 30, 2026.
Blackrock, Inc. is the largest disclosed holder, reporting approximately $602.16M in CPRX holdings in its latest filing.
Recent insider activity includes 13 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.
Institutional Holders
381
Total Reported Value
$3.33B
Largest Holder
Blackrock, Inc.
Largest Position
$602.16M
Insider Transactions (90d)
13
Latest Filing Quarter
Q2 2026
New Institutional Positions
100
Funds Exiting Positions
98
Top Institutional Owners
View all- Blackrock, Inc.$602.16M
- State Street Corp$239.72M
- American Century Companies Inc$174.56M
- Vanguard Capital Management Llc$161.40M
- Dimensional Fund Advisors Lp$114.22M
CPRX News
All news- Glazer Capital Q3 2026 Investment Activity Report
Aug 22, 2026 · valut.ai
- Oxford Asset Management Q2 2026 Portfolio Activity: Strategic Buys and Sells
Aug 20, 2026 · valut.ai
- Chicago Capital Management Increases Holdings in Key Growth Sectors
Jul 25, 2026 · valut.ai
Related CPRX Institutional Insights:
- CPRX 13F Institutional Holders
- CPRX Top Institutional Shareholders
- CPRX Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- CPRX Insider Trading & SEC Form 4 Activity
- CPRX Articles
- Top Institutional Investor Stock Rankings